Brandon Capital
About
Brandon Capital Brandon Capital was founded in 2007 and has grown into Australia's largest life sciences venture capital firm, surpassing $1B in total AUM. Fund VI closed at AU$439M (US$288M) in 2024, the largest to date. The firm is the licensed manager for the Australian Government's $500M Biomedical Translation Fund, which provides dollar- for-dollar matching, and the National Reconstruction Fund committed an additional $150M for next-generation Australian medical breakthroughs. The investmen
Industries
Stage focus
SeedSeries A
Geography
Rest of WorldEuropeUS
Notable investments
- Vaxxas
- AdvanCell
- Myricx Bio
- OncoRes Medical
- PolyActiva
Raising from Brandon Capital?
I've worked with founders across the industrial stack. If Brandon Capital is on your list, I can help you map the introduction path, sharpen the narrative, and run a tight process.
Talk to Dan